Skip to main content
HCPCS J1885 · Level II · Part B drug

J1885: ketorolac tromethamine, HCPCS Level II J code

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: ASP payment limits: October 2026 (effective October 1, 2026); NCCI MUE tables: 2026 Q4 (effective October 1, 2026); NCCI PTP edits: v323r0 (2026 Q4) (effective October 1, 2026); OPPS Addendum B: October 2026 (effective October 1, 2026); ASC Addendum BB (covered ancillary services): October 2026 (effective October 1, 2026). Next CMS release: January 1, 2027 (quarterly update).

Key facts for J1885

Billing unit
15 MG
Ketorolac tromethamine inj
ASP payment limit
$0.569
October 2026; +99.0% vs July 2026
Practitioner MUE
8
MAI 3
OPPS status
SI K1
APC 0764
NCCI exposure
no PTP pairs
Coverage articles
0
none list this code

TL;DR

HCPCS J1885 is the Level II code for Injection, ketorolac tromethamine, per 15 mg, billed per 15 MG. The Medicare Part B ASP payment limit for October 2026 is $0.569 per billing unit, up 99.0% from July 2026. The practitioner MUE allows up to 8 units per date of service (MAI 3), so a full 8-unit day is $4.55 at the current limit. Under OPPS it carries status indicator K1 in APC 0764. J1885 is billed in units of 15 MG; the quantity administered, the NDC package and the units on the claim must reconcile, which is the check that prevents CARC 16 and 151 returns on this line. The ASP crosswalk maps 71 NDCs to it, sold as Ketorolac Tromethamine by Baxter Healthcare Corporation, Henry Schein Inc., Pfizer Inc. No current Billing and Coding Article lists J1885, so coverage follows the FDA label, compendia and any applicable NCD.

Medicare Part B payment limit (ASP)

CMS sets the Part B payment limit for J1885 at $0.569 per 15 MG for October 2026, derived from manufacturer average sales price plus 6%, compared with $0.286 in July 2026. Beneficiary coinsurance is 20%.

ASP payment limits for J1885
QuarterPayment limitPerCoinsurance
October 2026$0.56915 MG20%
July 2026$0.28615 MG—
Source: CMS Medicare Part B Drug Payment Limit File. Commercial and Medicaid payers set their own rates.

NDC to HCPCS billing-unit conversion

The October 2026 ASP crosswalk maps 71 NDCs from 16 labelers to J1885. Report the NDC in the claim's drug segment and bill the number of J1885 units that equals the quantity administered divided by 15 MG; the last column gives units per full package.

NDCs that crosswalk to J1885
NDCDrug nameLabelerPackage sizeBilling units / package
00338-0069-10Ketorolac TromethamineBaxter Healthcare Corporation1 × 1010
00338-0072-25Ketorolac TromethamineBaxter Healthcare Corporation1 × 2550
00404-9952-01Ketorolac TromethamineHenry Schein Inc.1 × 11
00404-9996-01Ketorolac TromethamineHenry Schein Inc.1 × 12
00404-9997-02Ketorolac TromethamineHenry Schein Inc.2 × 14
00404-9998-01Ketorolac TromethamineHenry Schein Inc.1 × 11
00409-3793-01Ketorolac TromethaminePfizer Inc1 × 2525
00409-3793-25Ketorolac TromethaminePfizer Inc1 × 2525
00409-3795-01Ketorolac TromethaminePfizer Inc1 × 2550
00409-3795-25Ketorolac TromethaminePfizer Inc1 × 2550
00409-3796-01Ketorolac TromethaminePfizer Inc2 × 25100
00409-3796-25Ketorolac TromethaminePfizer Inc2 × 25100
00487-6232-01Ketorolac TromethamineNephron SC, Inc.2 × 30120
25021-0700-01Ketorolac TromethamineSagent Pharmaceuticals1 × 2525
25021-0701-01Ketorolac TromethamineSagent Pharmaceuticals1 × 2550
25021-0701-02Ketorolac TromethamineSagent Pharmaceuticals2 × 25100
50090-1328-01Ketorolac TromethamineA-S Medication Solutions2 × 14
50090-3364-00Ketorolac TromethamineA-S Medication Solutions1 × 2550
50090-3364-01Ketorolac TromethamineA-S Medication Solutions1 × 2550
50090-3397-01Ketorolac TromethamineA-S Medication Solutions2 × 25100
50090-4583-00Ketorolac TromethamineA-S Medication Solutions2 × 25100
50090-4635-00Ketorolac TromethamineA-S Medication Solutions2 × 25100
50090-4635-01Ketorolac TromethamineA-S Medication Solutions2 × 14
50090-5013-00Ketorolac TromethamineA-S Medication Solutions1 × 2550
50090-5013-01Ketorolac TromethamineA-S Medication Solutions1 × 12
50090-5428-00Ketorolac TromethamineA-S Medication Solutions1 × 2550
50090-5428-01Ketorolac TromethamineA-S Medication Solutions1 × 12
50090-5609-00Ketorolac TromethamineA-S Medication Solutions1 × 2525
50090-6772-00Ketorolac TromethamineA-S Medication Solutions2 × 25100
50090-6772-01Ketorolac TromethamineA-S Medication Solutions2 × 14
50090-6807-00Ketorolac TromethamineA-S Medication Solutions1 × 2525
51662-1292-01Ketorolac TromethamineHF Acquisition Co. LLC, DBA HealthFirst1 × 12
51662-1292-03Ketorolac TromethamineHF Acquisition Co. LLC, DBA HealthFirst1 × 2550
51662-1295-01Ketorolac TromethamineHF Acquisition Co. LLC, DBA HealthFirst2 × 14
51662-1295-03Ketorolac TromethamineHF Acquisition Co. LLC, DBA HealthFirst2 × 25100
51662-1594-03Ketorolac TromethamineHF Acquisition Co. LLC, DBA HealthFirst1 × 2550
62332-0599-25Ketorolac TromethamineAlembic Pharmaceuticals Inc.1 × 2525
62332-0600-25Ketorolac TromethamineAlembic Pharmaceuticals Inc.1 × 2550
62332-0601-25Ketorolac TromethamineAlembic Pharmaceuticals Inc.2 × 25100
63323-0161-01Ketorolac TromethamineFreseniUS Kabi USA, LLC1 × 2525
63323-0161-12Ketorolac TromethamineFreseniUS Kabi USA, LLC1 × 2525
63323-0161-16Ketorolac TromethamineFreseniUS Kabi USA, LLC1 × 2525
63323-0162-01Ketorolac TromethamineFreseniUS Kabi USA, LLC1 × 2550
63323-0162-02Ketorolac TromethamineFreseniUS Kabi USA, LLC2 × 25100
63323-0162-12Ketorolac TromethamineFreseniUS Kabi USA, LLC1 × 2550
63323-0162-14Ketorolac TromethamineFreseniUS Kabi USA, LLC2 × 25100
63323-0162-16Ketorolac TromethamineFreseniUS Kabi USA, LLC1 × 2550
63323-0162-26Ketorolac TromethamineFreseniUS Kabi USA, LLC2 × 25100
65145-0145-25Ketorolac TromethamineCaplin Steriles USA Inc.1 × 2550
65145-0146-25Ketorolac TromethamineCaplin Steriles USA Inc.1 × 2525
65145-0147-25Ketorolac TromethamineCaplin Steriles USA Inc.2 × 25100
68462-0755-25Ketorolac TromethamineGlenmark Pharmaceuticals Inc., USA1 × 2525
68462-0756-25Ketorolac TromethamineGlenmark Pharmaceuticals Inc., USA1 × 2550
68462-0757-25Ketorolac TromethamineGlenmark Pharmaceuticals Inc., USA2 × 25100
70512-0842-25Ketorolac TromethamineSola Pharmaceuticals1 × 2525
70512-0843-25Ketorolac TromethamineSola Pharmaceuticals1 × 2550
70512-0844-25Ketorolac TromethamineSola Pharmaceuticals2 × 25100
70860-0700-02Ketorolac TromethamineAthenex Pharmaceutical Division, LLC1 × 2525
70860-0701-03Ketorolac TromethamineAthenex Pharmaceutical Division, LLC1 × 2550
70860-0701-04Ketorolac TromethamineAthenex Pharmaceutical Division, LLC2 × 25100
Showing 60 of 71 NDCs.

Medically Unlikely Edits (MUE)

CMS publishes 3 MUE values for J1885. For practitioners the limit is 8 units per date of service with adjudication indicator 3, a date-of-service clinical edit: units above the limit deny but can be paid on appeal with documentation that the quantity was medically reasonable.

MUE values for J1885 by setting
SettingMUE (units/DOS)MAICMS rationale
Practitioner services83 Date of Service Edit: ClinicalPrescribing Information
Facility outpatient hospital83 Date of Service Edit: ClinicalPrescribing Information
DME supplier03 Date of Service Edit: ClinicalCMS Policy

MUE for J1885 in every setting opens the lookup with this code filled in, next to any other code on the same claim.

NCCI edits and add-on relationships

No active practitioner PTP pair lists J1885 as a column-1 or column-2 code in v323r0. Drug supply codes are rarely bundled; the administration codes billed with them are where PTP edits usually apply.

The counts above are exposure, not answers for a specific claim. Check J1885 against another code to see whether a given pair bundles, which code is paid and whether a modifier can separate them.

J1885 is neither an add-on code nor a designated primary code in the 2026 Q4 NCCI add-on edit file.

Medicare coverage articles

No current Billing and Coding Article lists J1885 in its HCPCS table. Coverage then follows the drug's FDA label, compendia and any National Coverage Determination; check the Medicare Coverage Database before administering off-label.

Hospital outpatient (OPPS) status

In the October 2026 OPPS Addendum B, J1885 carries status indicator K1 and is assigned to APC 0764, with a published national unadjusted payment of $0.569. The OPPS status indicator reference explains how status K1 is paid.

Ambulatory surgical center (ASC) payment

In the October 2026 ASC Addendum BB (covered ancillary services), J1885 carries payment indicator K2, which CMS defines as "Drugs, biologicals, and radiopharmaceuticals paid separately when provided integral to a surgical procedure on ASC list; payment based on OPPS rate". The national ASC payment is $0.57 per 15 MG, paid only when the drug is furnished integral to a covered surgical procedure.

Common denials for J1885 and how to prevent them

NDC missing, invalid or not matched to the HCPCS code

units billed exceed the MUE for the date of service

diagnosis not covered by the applicable coverage article or LCD

For teams evaluating QuickIntell software

Evaluate a coding workflow for J1885

Use the unit, NDC and edit questions in this reference to scope a QuickCode evaluation for qualified coder review, documentation clarification and the billing handoff. Confirm supported code sets, data inputs and reviewer responsibilities; the reference tables do not establish that a particular automated check or payer integration is available.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions — HCPCS J1885

What does HCPCS code J1885 describe?

J1885 is defined by CMS as "Injection, ketorolac tromethamine, per 15 mg". Each billing unit represents 15 MG, so the units reported on the claim must equal the dose administered divided by that unit.

Is J1885 a CPT code?

No. J1885 is a HCPCS Level II code, the letter-plus-four-digit set CMS maintains for drugs such as ketorolac tromethamine; CPT codes are five-character codes maintained by the AMA. On a Part B claim J1885 reports the drug itself in 15 mg units, and the administration is billed on its own line.

What is the Medicare reimbursement for J1885 in October 2026?

The ASP-based payment limit is $0.569 per 15 MG, with 20% beneficiary coinsurance. The July 2026 limit was $0.286. Commercial payers use their own fee schedules.

How many units of J1885 can be billed per day?

The practitioner Medically Unlikely Edit is 8 units per date of service with adjudication indicator 3 (Date of Service Edit: Clinical). MAI 3 edits can be appealed with documentation that the units were medically reasonable. CMS cites "Prescribing Information" as the rationale.

Which NDCs map to J1885?

The October 2026 ASP crosswalk lists 71 NDCs from 16 labelers: Ketorolac Tromethamine (Baxter Healthcare Corporation); Ketorolac Tromethamine (Henry Schein Inc.); Ketorolac Tromethamine (Pfizer Inc); Ketorolac Tromethamine (Nephron SC, Inc.). For example NDC 00338-0069-10 (package size 1) equals 10 billing units of J1885.

Does J1885 have NCCI bundling edits?

No active practitioner PTP pairs list J1885 as a column-1 or column-2 code in the v323r0 release.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

This page is an operational reference compiled from CMS publications: the Medicare Part B drug payment limit and NDC crosswalk files, NCCI MUE and add-on edit tables, aggregate PTP statistics, OPPS Addendum B, ASC Addendum BB and the Medicare Coverage Database. Payment limits and rates are Medicare national amounts; commercial and Medicaid payers differ. CPT codes are shown as numbers only; CPT descriptors are copyright AMA. Nothing here is legal, clinical or billing advice.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.